[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE301991T1 - Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung - Google Patents

Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung

Info

Publication number
ATE301991T1
ATE301991T1 AT97947786T AT97947786T ATE301991T1 AT E301991 T1 ATE301991 T1 AT E301991T1 AT 97947786 T AT97947786 T AT 97947786T AT 97947786 T AT97947786 T AT 97947786T AT E301991 T1 ATE301991 T1 AT E301991T1
Authority
AT
Austria
Prior art keywords
hfc
container
carrier
administration
devices
Prior art date
Application number
AT97947786T
Other languages
English (en)
Inventor
Paul Mccarthy
Michael Goodman
Ake Lindahl
Original Assignee
Link Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625171.5A external-priority patent/GB9625171D0/en
Priority claimed from GBGB9626449.4A external-priority patent/GB9626449D0/en
Application filed by Link Products Ltd filed Critical Link Products Ltd
Application granted granted Critical
Publication of ATE301991T1 publication Critical patent/ATE301991T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
AT97947786T 1996-12-04 1997-12-04 Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung ATE301991T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625171.5A GB9625171D0 (en) 1996-12-04 1996-12-04 Pharmaceutical compositions and devices for their administration
GBGB9626449.4A GB9626449D0 (en) 1996-12-20 1996-12-20 Pharmaceutical compositions and device for their administration
PCT/GB1997/003360 WO1998024420A1 (en) 1996-12-04 1997-12-04 Pharmaceutical compositions and devices for their administration

Publications (1)

Publication Number Publication Date
ATE301991T1 true ATE301991T1 (de) 2005-09-15

Family

ID=26310542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97947786T ATE301991T1 (de) 1996-12-04 1997-12-04 Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung

Country Status (13)

Country Link
EP (1) EP1011646B1 (de)
JP (1) JP2001505171A (de)
KR (1) KR20000069275A (de)
AT (1) ATE301991T1 (de)
AU (1) AU726510B2 (de)
CA (1) CA2273835A1 (de)
DE (1) DE69734017T2 (de)
DK (1) DK1011646T3 (de)
ES (1) ES2244008T3 (de)
IE (1) IES970858A2 (de)
NO (1) NO992677L (de)
NZ (1) NZ336049A (de)
WO (1) WO1998024420A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
DE60031504T2 (de) * 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
GB2385596B (en) * 1999-09-11 2004-03-03 Glaxo Group Ltd Container for pharmaceutical formulation of fluticasone propionate
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
NZ544681A (en) 2000-03-09 2008-02-29 Gw Pharma Ltd Sub-lingual administration of cannabis
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
GB0015361D0 (en) * 2000-06-22 2000-08-16 Pharmasol Ltd Improvements in pharmaceutical compositions
AU2001274307A1 (en) * 2000-06-22 2002-01-02 Pharmasol Ltd Pharmaceutical compositions
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1321159A1 (de) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Betätigungsvorrichtung für Druckdosierinhalator mit lasergebohrten Löchern
AU2002361850A1 (en) * 2001-12-21 2003-07-30 3M Innovative Properties Company Medicinal aerosol formulations comprising ion pair complexes
US7255102B2 (en) 2002-02-01 2007-08-14 Generex Pharmaceuticals Inc. Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
EP1340492A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
KR100776770B1 (ko) * 2006-07-18 2007-11-29 (주)비엔에프 고압분사 에어로졸 밸브
US8578942B2 (en) 2010-05-25 2013-11-12 British American Tobacco (Investments) Limited Aerosol generator
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
RU2541312C2 (ru) * 2011-08-31 2015-02-10 Александр Васильевич Иващенко Фармацевтическая композиция, способ ее получения и устройство для ее применения
WO2017115827A1 (ja) * 2015-12-28 2017-07-06 花王株式会社 エアゾール化粧料
WO2024128510A1 (ko) * 2022-12-13 2024-06-20 주식회사 대웅제약 비강용 투약장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6907687A (en) * 1986-02-18 1987-08-20 Rorer Pharmaceutical Corporation Composition for treatment of asthmatic conditions using phenoxymethyl quinolines
ES2064160T3 (es) * 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
HUT67445A (en) * 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2-tetrafluorethane
FR2705570B1 (fr) * 1993-05-25 1995-07-13 Adir Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
US6149892A (en) * 1995-04-14 2000-11-21 Glaxowellcome, Inc. Metered dose inhaler for beclomethasone dipropionate
GB9517998D0 (en) * 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration

Also Published As

Publication number Publication date
ES2244008T3 (es) 2005-12-01
WO1998024420A1 (en) 1998-06-11
CA2273835A1 (en) 1998-06-11
NO992677L (no) 1999-07-15
KR20000069275A (ko) 2000-11-25
AU5402898A (en) 1998-06-29
EP1011646B1 (de) 2005-08-17
DE69734017T2 (de) 2006-06-14
IES80485B2 (en) 1998-08-12
DE69734017D1 (de) 2005-09-22
DK1011646T3 (da) 2005-09-19
EP1011646A1 (de) 2000-06-28
NZ336049A (en) 2000-09-29
AU726510B2 (en) 2000-11-09
NO992677D0 (no) 1999-06-02
IES970858A2 (en) 1998-08-12
JP2001505171A (ja) 2001-04-17

Similar Documents

Publication Publication Date Title
ATE301991T1 (de) Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung
US6413496B1 (en) Pharmaceutical compositions and devices for their administration
CA2477879A1 (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
JP3266005B2 (ja) エアゾール製剤およびその製造方法
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
EP2800571B1 (de) Oromukosala flüssige östradiol zusammensetzungen
US20120328718A1 (en) Pharmaceutical compositions
WO2001043722A3 (en) Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
NZ233415A (en) Pharmaceutical foam for rectal administration of 5-aminosalicylic acid; dispenser
EP1277467A3 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
HK130397A (en) Aerosol formulation comprising beclomethasone 17,21 dipropionate
GEP20012462B (en) Composition for Aerosol Inhaler, Aerosol Inhaler and Method for Filling with the Composition
CA2311450A1 (en) Pharmaceutical aerosol compositions
YU59899A (sh) Medicinski aerosolni proizvodi
ATE180665T1 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
KR970705997A (ko) N-{4-[2-(1, 2, 3, 4-테트라히드로-6, 7-디메톡시-2-이소퀴놀리닐)-에틸]-페닐}-9, 10-디히드로-5-메톡시-9-옥소-4-아크리딘 카르복사미드 화합물(gf120918a)을 포함하는 비경구 제약 조성물(parenteral pharmaceutical compositions containing gf120918a)
HK1029277A1 (en) Pharmaceutical coating composition and method of use.
AU2127400A (en) A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
ES2141049A1 (es) Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
MX9604004A (es) Formualciones de farmaco en aerosol que contienen vitamina e.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011646

Country of ref document: EP

REN Ceased due to non-payment of the annual fee